Riskpilot← Back to searchSign inGet full accessneurizon ApS
APSActiveCVR 36889845Søtoften 43All other professional, scientific and technical activities n.e.c. · NACE 7499Est. 2015— employees
Revenue 2024
DKK 0
EBITDA margin
—
+235% vs 2023
Equity ratio
100.0%
Financial strength
Net profit 2024
DKK -585
-137% vs 2023
| Revenue | DKK 0 | — |
| EBITDA | DKK 2K | +235% |
| Net profit | DKK -585 | -137% |
| Total assets | DKK 91K | -3% |
| Equity | DKK 91K | -3% |
| Employees | — | — |
Legal name
neurizon ApS
CVR number
36889845
Legal form
Anpartsselskab
NACE code
7499 · All other professional, scientific and technical activities n.e.c.
Founded
1. maj 2015
Share capital
DKK 51.000
Employees
—
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af den samlede bestyrelse eller af bestyrelsesformanden og direktøren i forening.
Company purpose
Virksomhedens formål er at udvikle og sælge forskningsdatabaser og sundheds-IT samt aktiviteter, som knytter sig hertil.
Address
Søtoften 43
Phone
+4529161929
Email
neurologic@dadlnet.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5 | -13 | 1 | 0 | 37 | 112 | -32 | 7 | 0 | 0 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | 5 | -13 | 1 | -6 | 32 | 107 | -32 | 7 | -1 | 2 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | 5 | -13 | 1 | -6 | 32 | 107 | -32 | 7 | -1 | 2 |
| Net financials | -3 | -4 | -4 | -4 | 0 | 0 | 0 | -4 | -3 | -2 |
| Profit before tax | 2 | -17 | -3 | -10 | 32 | 107 | -32 | 2 | 2 | -1 |
| Tax | 2 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Net profit | -0 | -17 | -3 | -10 | 32 | 107 | -32 | 2 | 2 | -1 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 81 | 48 | 36 | 34 | 55 | 163 | 124 | 97 | 93 | 91 |
| Equity | 51 | 34 | 30 | 34 | 55 | 163 | 124 | 97 | 93 | 91 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 31 | 14 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total debt | 31 | 14 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBITDA margin
201600.0%
This company
15.8%
Market median
+1275849% vs market
20152024
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20152024
Return on equity
-0.6%
This company
18.4%
Market median
-103% vs market
20152024
Net profit margin
-58500.0%
This company
8.1%
Market median
-722322% vs market
20152024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20152024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20152024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-05-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
KS Chief Executive Officer | Chief Executive Officer | 2015 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2015 | — | — | |
| Board of Directors | 2015 | — | — | |
| Chairman | 2015 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 25.0% | 25.0% | 2015 | |
ITMEDICO HOLDING ApS | Company | 25.0% | 25.0% | 2015 |
Neurologic Holding ApS | Company | 25.0% | 25.0% | 2023 |
KYNOS ApS | Company | 25.0% | 25.0% | 2015 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
ITMEDICO HOLDING ApS
neurizon ApS Board members of neurizon ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kaare Stenhøj Meier | Chief Executive Officer | 0 companies |
| Mattias karl Johan Valdemar Rasmusson | Board of Directors | 0 companies |
| Morten Flink | Board of Directors | 0 companies |
| Jens Christian Hedemann Sørensen | Chairman | 0 companies |